Intravenous immunoglobulin (also referred to as IVIG) is a product made up of antibodies that can be given intravenously. According to the American College of Rheumatology, it is prepared from a pool of immunoglobulins (antibodies) from the plasma of thousands of healthy donors.
Immunoglobulins are made by the immune system of healthy people to fight infections. While IVIG is derived from plasma (a blood product), it is so purified that the chances of contracting a blood-borne infection are extremely low.
Traditionally, IVIG has been used as replacement therapy for patients with primary or secondary immunoglobulin deficiencies.
DelveInsight’s “Intravenous Immunoglobulin Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Intravenous Immunoglobulin , historical and forecasted epidemiology as well as the Intravenous Immunoglobulin market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some facts of Intravenous Immunoglobulin Market:
- According to the NORD (National Organization for Rare Disorders), the incidence of ITP among adults in the United States is estimated to be around 3.3/100,000 adults/year.
- As per the article by Gelfand, approximately 25–30% of IVIG used in the United States remains as replacement therapy for primary immunodeficiency disease (PID).
- At present the market is currently dominated by the some of the key players, which includes Takeda (Baxter), Bio Products Laboratory, Grifols, CSL Behring, Octapharma, Kedrion Biopharma, and others.
- Primary immunodeficiency diseases (PI) are a group of more than 400 rare, chronic disorders in which part of the body’s immune system is missing or functions improperly
Request for free Sample: https://www.delveinsight.com/sample-request/intravenous-immunoglobulin-market
Scope of the Intravenous Immunoglobulin Report:
- The report covers the descriptive overview of Intravenous Immunoglobulin , explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
- Comprehensive insight has been provided into the Intravenous Immunoglobulin epidemiology and treatment in the 7MM
- Additionally, an all-inclusive account of both the current and emerging therapies for Intravenous Immunoglobulin are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
- A detailed review of Intravenous Immunoglobulin market; historical and forecasted is included in the report, covering drug outreach in the 7MM
- The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Intravenous Immunoglobulin market
Request for free Sample: https://www.delveinsight.com/sample-request/intravenous-immunoglobulin-market
Some of Intravenous Immunoglobulin Companies are:
- Evolve Biologics
- Biotest
- Momenta Pharmaceuticals
- Green Cross Pharma
- And Many Others
Some of Intravenous Immunoglobulin Drugs are:
- PlasmaCap IG 10%
- BT595
- M254
- GC5101B
- And Many Others
At present the market is currently dominated by the some of the key players, which includes Takeda (Baxter), Bio Products Laboratory, Grifols, CSL Behring, Octapharma, Kedrion Biopharma, and others.
Request for free Sample: https://www.delveinsight.com/sample-request/intravenous-immunoglobulin-market
Table of Contents:
1. Key Insights
2. Executive Summary of Intravenous Immunoglobulin
3. Competitive Intelligence Analysis for Intravenous Immunoglobulin
4. Intravenous Immunoglobulin : Market Overview at a Glance
5. Intravenous Immunoglobulin : Disease Background and Overview
6. Patient Journey
7. Intravenous Immunoglobulin Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Intravenous Immunoglobulin Treatment
11. Marketed Products
List to be continued in report
12. Emerging Therapies
List to be continued in report
13. Intravenous Immunoglobulin : Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Intravenous Immunoglobulin
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Request for Deatiled TOC: https://www.delveinsight.com/sample-request/intravenous-immunoglobulin-market
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/intravenous-immunoglobulin-market